BO
BioInvent International AB (publ)
BOVNF · OTC
$6.63 +101.61% (+$3.34)
Market Cap 2.13B kr
P/E Ratio -
Div. Yield -
ROE 99.64%
Bulios Fair Price
$4.12
37.9% downside
Trenutna cena
$6.63
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BOVNF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
8 /100
Expensive P/S 65.67x
P/B 6.76x
P/E N/A
Growth
0 /100
Declining Rev. growth 11.52%
Book val. growth 29.78%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 50.78%
Net margin 1,530.01%
Op. margin 1,568.54%
Quality
1 /100
Poor ROIC 151.28%
ROE 99.64%
ROA 117.84%
Debt
100 /100
Low Debt/Equity 0.07x
Current ratio 4.06x
Int. coverage N/A
Stability
1 /100
Unstable Beta 0.02x
Rev. volatility 268.29%
EPS volatility 467.73%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BOVNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Martin Welschof
Employees
109
Headquarters
Lund
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report